Your shopping cart is currently empty

Spathulenol is a natural ingredient from Aristolochia yunnanensis that has anti-inflammatory, antioxidant, anti-proliferation, anti-ulcer and anti-mycobacterium activities. Spathulenol showed significant antioxidant activity in DPPH system with IC50 of 85.60 μg/mL.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $158 | - | In Stock | |
| 2 mg | $237 | - | In Stock |
| Description | Spathulenol is a natural ingredient from Aristolochia yunnanensis that has anti-inflammatory, antioxidant, anti-proliferation, anti-ulcer and anti-mycobacterium activities. Spathulenol showed significant antioxidant activity in DPPH system with IC50 of 85.60 μg/mL. |
| Targets&IC50 | DPPH&MDA:85.60 μg/mL |
| In vitro | In the DPPH and MDA systems, spathulenol demonstrates high antioxidant activity. It shows significant DPPH free radical activity, with IC50 values of 85.60 μg/mL[1]. |
| In vivo | Spathulenol, when administered orally at a dose of 300 mg/kg, demonstrates significant inhibition in the mice paw edema and pleurisy model induced by Cg[1]. In a spontaneous lipoperoxidation model using rat brain homogenate, when incubated under controlled temperature and oxygenation conditions, PG-1 exhibits high activity with an IC50 value of 26.13 μg/mL. This activity is comparable to that of the commercial antioxidant BHT (38.41 μg/mL). Consequently, PG-1 contributes to a reduction in the generation of malondialdehyde (MDA), a toxic product resulting from the degradation of cell membranes through lipid peroxidation. This reduction in MDA levels helps prevent cell ruptures and mutations[1]. |
| Molecular Weight | 220.35 |
| Formula | C15H24O |
| Cas No. | 6750-60-3 |
| Smiles | [H][C@@]12CCC(=C)[C@]3([H])CC[C@](C)(O)[C@@]3([H])[C@]1([H])C2(C)C |
| Relative Density. | 1.02g/cm3 |
| Storage | store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 90 mg/mL (408.44 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (14.98 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.